Skip to main content

Multiple System Atrophy clinical trials at UCSF

2 research studies open to eligible people

Showing trials for
  • A Study of Lu AF82422 in Participants With Multiple System Atrophy

    open to eligible people ages 40-75

    To find out the effect of Lu AF82422 on disease progression in participants with multiple system atrophy.

    San Francisco, California and other locations

  • Trial of Parkinson's And Zoledronic Acid

    open to eligible people ages 60 years and up

    This home-based study is a randomized (1:1) placebo-controlled trial of a single infusion of zoledronic acid-5 mg (ZA) for the prevention of fractures in men and women aged 60 years and older with Parkinson's disease and parkinsonism with at least 2 years of follow-up. A total of 3500 participants will be enrolled and randomized in the United States. Participants, follow-up outcome assessors, and study investigators will be blinded to assigned study treatment. This trial is funded by the National Institute of Aging.

    San Francisco, California and other locations

Our lead scientists for Multiple System Atrophy research studies include .

Last updated: